HighPoint Advisor Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.8M | Buy |
4,037
+26
| +0.6% | +$11.6K | 0.1% | 170 |
|
|
2025
Q1 | $2.02M | Buy |
4,011
+406
| +11% | +$204K | 0.12% | 140 |
|
|
2024
Q4 | $1.64M | Buy |
3,605
+120
| +3% | +$54.6K | 0.09% | 179 |
|
|
2024
Q3 | $1.64M | Sell |
3,485
-943
| -21% | -$444K | 0.1% | 166 |
|
|
2024
Q2 | $2.23M | Buy |
4,428
+506
| +13% | +$254K | 0.13% | 130 |
|
|
2024
Q1 | $1.69M | Buy |
3,922
+334
| +9% | +$144K | 0.12% | 145 |
|
|
2023
Q4 | $1.49M | Buy |
+3,588
| New | +$1.49M | 0.11% | 153 |
|
|
2022
Q2 | $511K | Buy |
+1,754
| New | +$511K | 0.06% | 282 |
|
|
2021
Q3 | – | Sell |
-1,100
| Closed | -$222K | – | 599 |
|
|
2021
Q2 | $222K | Buy |
+1,100
| New | +$222K | 0.02% | 475 |
|
|
2020
Q3 | – | Sell |
-2,508
| Closed | -$718K | – | 406 |
|
|
2020
Q2 | $718K | Buy |
2,508
+103
| +4% | +$29.5K | 0.15% | 123 |
|
|
2020
Q1 | $649K | Sell |
2,405
-790
| -25% | -$213K | 0.15% | 115 |
|
|
2019
Q4 | $747K | Buy |
+3,195
| New | +$747K | 0.15% | 120 |
|
|
2019
Q2 | – | Sell |
-5,041
| Closed | -$858K | – | 503 |
|
|
2019
Q1 | $858K | Sell |
5,041
-56
| -1% | -$9.53K | 0.21% | 93 |
|
|
2018
Q4 | $952K | Buy |
5,097
+160
| +3% | +$29.9K | 0.25% | 94 |
|
|
2018
Q3 | $876K | Hold |
4,937
| – | – | 0.24% | 101 |
|
|
2018
Q2 | $864K | Buy |
+4,937
| New | +$864K | 0.23% | 113 |
|